- Home
- JCTCF vs PMCB Comparison
JCTCF vs PMCB Comparison
Compare JCTCF & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCTCF
- PMCB
- Stock Information
- Founded
- JCTCF 1953
- PMCB 1996
- Country
- JCTCF United States
- PMCB United States
- Employees
- JCTCF N/A
- PMCB N/A
- Industry
- JCTCF RETAIL: Building Materials
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JCTCF Consumer Discretionary
- PMCB Health Care
- Exchange
- JCTCF Nasdaq
- PMCB Nasdaq
- Market Cap
- JCTCF 14.3M
- PMCB 15.8M
- IPO Year
- JCTCF 1996
- PMCB N/A
- Fundamental
- Price
- JCTCF $4.89
- PMCB $1.81
- Analyst Decision
- JCTCF
- PMCB
- Analyst Count
- JCTCF 0
- PMCB 0
- Target Price
- JCTCF N/A
- PMCB N/A
- AVG Volume (30 Days)
- JCTCF 6.5K
- PMCB 37.3K
- Earning Date
- JCTCF 11-26-2024
- PMCB 09-17-2024
- Dividend Yield
- JCTCF N/A
- PMCB N/A
- EPS Growth
- JCTCF N/A
- PMCB N/A
- EPS
- JCTCF 0.34
- PMCB 0.54
- Revenue
- JCTCF $48,553,695.00
- PMCB N/A
- Revenue This Year
- JCTCF N/A
- PMCB N/A
- Revenue Next Year
- JCTCF N/A
- PMCB N/A
- P/E Ratio
- JCTCF $14.68
- PMCB $3.29
- Revenue Growth
- JCTCF N/A
- PMCB N/A
- 52 Week Low
- JCTCF $3.86
- PMCB $1.39
- 52 Week High
- JCTCF $6.35
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- JCTCF 57.41
- PMCB 50.47
- Support Level
- JCTCF $4.89
- PMCB $1.72
- Resistance Level
- JCTCF $4.99
- PMCB $1.95
- Average True Range (ATR)
- JCTCF 0.07
- PMCB 0.23
- MACD
- JCTCF -0.00
- PMCB -0.01
- Stochastic Oscillator
- JCTCF 38.89
- PMCB 48.33
About JCTCF Jewett-Cameron Trading Company
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in United States and also has its presence in Canada, Latin America, Europe and Asia and other regions.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.